DSE/BEACONPHAR (DSE/BEACONPHAR)

Dhaka Stock Exchange: DSE/BEACONPHAR · BDT

BDT 93.3

+2.20 (+2.4%)· Recorded snapshot

Market cap	21.6B
Revenue (ttm)	15.6B
Net income (ttm)	1.5B
EPS (ttm)	BDT 6.31
Shares out	231M
P/E (trailing)	14.8x
Dividend	BDT 2.10 (2.25%)
Volume	84,117
Beta	-0.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.6B
Net income (ttm): 1.5B
EPS (ttm): BDT 6.31
P/E (trailing): 14.8x
Market cap: 21.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E14.8

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC14.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DSE/BEACONPHAR indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

BDT

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2026-10-19
Employees	4,771
Employees change	609
Employees growth	14.63%
Enterprise value	BDT 30.6B
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	June
Founded	2001
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	BD0482BECON5
Last earnings date	2026-04-27
Last refreshed	2026-10-29
Last stock split date	2011-11-27
Last stock split type	Forward
Market cap	BDT 21.6B
Price	BDT 93.30
Price currency	BDT
SIC code	2834
Stock price date	2026-10-28
Symbol	dse/BEACONPHAR
Website	https://www.beaconmedicare.com.bd

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	54.5x
Average P/E ratio (3Y)	57.48x
Average P/E ratio (5Y)	59.24x
Earnings yield	6.76%
EV/Earnings	21x
EV/EBIT	9.93x
EV/EBITDA	8.33x
EV/FCF	20.46x
EV/Sales	1.97x
FCF / EV yield	4.89%
FCF yield	6.94%
Graham number	68.99987
Graham upside	-26.05%
Industry P/E	9.78x
Lynch fair value	BDT 48.29
Lynch upside	-48.24%
P/B ratio	2.78x
P/E ratio	14.79x
P/FCF ratio	14.41x
P/OCF ratio	8.54x
P/S ratio	1.38x
Price / tangible book value	2.78x
Price/EBITDA ratio	5.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.8%
EBITDA margin	23.4%
Effective tax rate	27.82%
FCF margin	9.61%
Gross margin	51.95%
Operating margin	19.8%
Pretax margin	12.97%
Profit margin	9.36%
Profit per employee	BDT 305,379
Revenue per employee	BDT 3.3M
ROA (5Y)	8.09%
ROCE	25.66%
ROE (5Y)	13.18%
ROIC	14.39%
ROIC (5Y)	10.43%
Tax / revenue	3.61%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	74.11%
EPS growth (Q)	-36.08%
EPS growth (QoQ)	-50.76%
EPS growth 10Y	37.94%
EPS growth 3Y	27.75%
EPS growth 5Y	7.66%
FCF growth	-21.97%
FCF growth (Q)	-43.94%
FCF growth (QoQ)	-64.07%
Gross profit growth	30.24%
Gross profit growth (Q)	26.11%
Gross profit growth 3Y	27.84%
Gross profit growth 5Y	15.44%
Net income growth	74.11%
Net income growth (Q)	-36.08%
Net income growth (QoQ)	-50.76%
Net income growth 3Y	27.75%
Net income growth 5Y	7.66%
OCF growth	-9.35%
OCF growth (Q)	-15.91%
OCF growth (QoQ)	-44.82%
OCF growth 10Y	28.36%
OCF growth 3Y	23.17%
OCF growth 5Y	51.09%
Operating income growth	34.52%
Operating income growth (Q)	-21.7%
Operating income growth 3Y	36.89%
Operating income growth 5Y	20.85%
Revenue growth	30.15%
Revenue growth (Q)	25.86%
Revenue growth (QoQ)	-7.9%
Revenue growth 10Y	21.18%
Revenue growth 3Y	23.87%
Revenue growth 5Y	15.06%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BDT -1B
Depreciation and amortization	BDT 560.5M
EBIT	BDT 3.1B
EBITDA	BDT 3.6B
EPS	BDT 6.31
FCF per share	BDT 6.47
Financing cash flow	BDT -1.2B
Free cash flow	BDT 1.5B
Gross profit	BDT 8.1B
Income taxes	BDT 561.6M
Investing cash flow	BDT -1.2B
Net borrowing	BDT -948.3M
Net cash flow	BDT 132.8M
Net income	BDT 1.5B
Operating income	BDT 3.1B
Revenue	BDT 15.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.04
Book value per share	BDT 33.55
Debt / EBITDA	2.57
Debt / equity	1.22
Debt / FCF	6.32
Interest coverage	2.36
Long-term assets	BDT 6.6B
Long-term liabilities	BDT 4.3B
Net cash (debt)	BDT -9B
Net cash / market cap	-41.94%
Net debt / EBITDA	2.48
Net debt / equity	1.17
Net debt / FCF	6.04
Piotroski F-Score	4
Property, plant and equipment	BDT 6.6B
Shareholders' equity	BDT 7.7B
Tangible book value	BDT 7.7B
Tangible book value per share	BDT 33.50
Total assets	BDT 20.9B
Total cash	BDT 412.3M
Total debt	BDT 9.5B
Total liabilities	BDT 13.1B
WACC	5.64%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	BDT 14.3B
Current liabilities	BDT 8.9B
Current ratio	1.61
Net working capital	BDT 11.4B
Quick ratio	0.46
Working capital	BDT 5.4B
Working capital turnover	3.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	-47.62%
Dividend growth (3Y)	-11.74%
Dividend growth (5Y)	-6.01%
Dividend growth years	2
Dividend payment date	2027-01-12
Dividend payment years	11
Dividend payout frequency	Annual
Dividend per share	BDT 2.10
Dividend yield	2.25%
Ex-dividend date	2026-11-11
FCF payout ratio	16.99%
Last dividend	BDT 1.10
Payout ratio	18.46%
Shareholder yield	2.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	412.64%
10Y return CAGR	19.78%
10Y total return	507.6%
150-day SMA	BDT 104.26
15Y price change	220.15%
15Y return CAGR	9.3%
15Y total return	279.45%
1D price change	2.41%
1M price change	-8.17%
1M total return	-8.17%
1W price change	-0.96%
1W total return	-0.96%
1Y price change	-13.45%
1Y return CAGR	-11.64%
1Y total return	-11.64%
20-day SMA	BDT 99.23
200-day SMA	BDT 104.48
3M price change	-13.85%
3M total return	-13.85%
3Y price change	-61.92%
3Y return CAGR	-26.42%
3Y total return	-60.18%
50-day SMA	BDT 101.77
50-day SMA vs 200-day SMA	50under200
52-week high	BDT 117.90
52-week high date	2026-07-06
52-week low	BDT 90.60
52-week low date	2026-10-27
5Y price change	-55.36%
5Y return CAGR	-13.92%
5Y total return	-52.74%
6M price change	-6.89%
6M total return	-6.89%
All-time high	BDT 393.00
All-time high date	2022-09-20
All-time low	BDT 11.10
All-time low date	2013-10-28
Average true range (ATR)	BDT 2.65
Average volume	87.5K
Beta (1Y)	0.35
Beta (2Y)	-0.02
Beta (5Y)	-0.09
Change from 52-week high	-20.87%
Change from 52-week low	2.98%
Change from all-time high	-76.26%
Change from all-time low	740.54%
Change from open	2.41%
Day's gap	0%
Dollar volume	BDT 7.8M
High price	BDT 94.00
Low price	BDT 91.10
Monthly RSI	34.14
Open price	BDT 91.10
Position in 52-week range	75.86%
Previous close	BDT 91.10
Price vs 150-day SMA	-10.51%
Price vs 20-day SMA	-5.98%
Price vs 200-day SMA	-10.7%
Price vs 50-day SMA	-8.33%
Relative volume	0.96
RSI	33.49
Sharpe ratio	-0.85
Sharpe ratio (3Y)	-0.7
Sharpe ratio (5Y)	-0.01
Sortino ratio	-1.03
Sortino ratio (3Y)	-0.93
Sortino ratio (5Y)	0.15
Volume	84.1K
Weekly RSI	0
YTD price change	-10.8%
YTD total return	-10.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0%
Shares outstanding	231M

Deeper analysis on DSE/BEACONPHAR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DSE/BEACONPHAR report

Is a complete DSE/BEACONPHAR research report available?

No complete published report is available for dse/BEACONPHAR (DSE/BEACONPHAR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/BEACONPHAR (DSE/BEACONPHAR)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/BEACONPHAR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/BEACONPHAR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/BEACONPHAR

Frequently asked questions